Menu Search
Equities

Dingdang Health Technology Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
9886:HKG.HS

Dingdang Health Technology Group Ltd

Actions
  • Price (HKD)0.88
  • Today's Change0.00 / 0.00%
  • Shares traded146.00k
  • 1 Year change+77.78%
  • Beta0.5241
Data delayed at least 15 minutes, as of Feb 13 2026 07:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Dingdang Health Technology Group Ltd is an investment holding company principally engaged in the provision of pharmaceutical and healthcare business. The Company is mainly engaged in three businesses. The drug express business mainly sells products through online direct sales, business distribution and offline retail channels, provides express medicine, medical and healthcare services, as well as advertisement, promotion, marketing service and research and development for pharmaceutical products. The online medical consultation business mainly provides users with online consultation services such as medication, nutrition and healthcare services through applied pharmaceutical artificial intelligence (AI) products, Dingdang Pharmacist and Nutritionist AI Assistant. The chronic diseases and health management business mainly provides users with health portfolio management and directly observed therapy (DOT) medication adherence services.

  • Revenue in HKD (TTM)5.35bn
  • Net income in HKD-389.25m
  • Incorporated2014
  • Employees2.27k
  • Location
    Dingdang Health Technology Group LtdDengshikou StreetDongcheng District, Building 1, Yard 50BEIJING ChinaCHN
  • Websitehttps://www.ddjkjt.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.